Serious Hazards of Transfusion (SHOT) Annual Report 2004
| dc.contributor.author | Serious Hazards of Transfusion (SHOT) | |
| dc.date.accessioned | 2023-03-04T13:29:59Z | |
| dc.date.available | 2023-03-04T13:29:59Z | |
| dc.description | SHOT is affiliated to the Royal College of Pathologists | en_US |
| dc.description.abstract | 2004 was a momentous one for all involved in the provision of blood transfusion, with the implementation of the European Union (EU) Directive on Blood Safety and Quality. The Directive was incorporated into UK legislation on 8th February 2005 as the Blood Safety and Quality Regulations, and will be implemented on 8th November. It requires that Blood Establishments and Hospital Blood Banks report to the Secretary of State for Health, 'all serious adverse reactions attributable to the safety or quality of blood', and 'all serious adverse events related to the collection, testing, processing, storage and distribution of blood and blood components that may have an influence on their quality and safety'. The EU Directive does not encompass no harm errors in clinical areas, which account for 70% of Incorrect Blood Components Transfused (IBCT) events. It is therefore vital that hospitals continue to report these events to SHOT in order to preserve the safety culture that we have established in the UK and to provide continuity of data for monitoring of the NPSA/NBTC/SHOT initiative outlined below, and other blood safety initiatives. | |
| dc.identifier.citation | Serious Hazards of Transfusion (SHOT) Writing Group. (2005). Serious Hazards of Transfusion (SHOT) Annual Report 2004. Pgs 1-51. | en_US |
| dc.identifier.issn | 0953278972 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12417/1357 | |
| dc.language.iso | en | en_US |
| dc.subject | Serious Hazards of Transfusion | en_US |
| dc.subject | Blood Transfusion | en_US |
| dc.subject | Transfusion Reaction | en_US |
| dc.title | Serious Hazards of Transfusion (SHOT) Annual Report 2004 | en_US |
| dcterms.dateAccepted | 2022-12-19 | |
| dspace.entity.type | Publication | |
| html.description.abstract | 2004 was a momentous one for all involved in the provision of blood transfusion, with the implementation of the European Union (EU) Directive on Blood Safety and Quality. The Directive was incorporated into UK legislation on 8th February 2005 as the Blood Safety and Quality Regulations, and will be implemented on 8th November. It requires that Blood Establishments and Hospital Blood Banks report to the Secretary of State for Health, 'all serious adverse reactions attributable to the safety or quality of blood', and 'all serious adverse events related to the collection, testing, processing, storage and distribution of blood and blood components that may have an influence on their quality and safety'. The EU Directive does not encompass no harm errors in clinical areas, which account for 70% of Incorrect Blood Components Transfused (IBCT) events. It is therefore vital that hospitals continue to report these events to SHOT in order to preserve the safety culture that we have established in the UK and to provide continuity of data for monitoring of the NPSA/NBTC/SHOT initiative outlined below, and other blood safety initiatives. | en_US |
| refterms.dateFOA | 2023-03-04T13:30:00Z | |
| refterms.panel | Unspecified | en_US |
| rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | en_US |
| rioxxterms.type | Technical Report | en_US |
| rioxxterms.version | NA | en_US |